15.11
Blind Procedures
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to c…
Individuals can enter into studies with biases that skew results, portraying a treatment as being more effective than it actually is.
For instance, during an insomnia study, a researcher may place a sleep-aid or placebo tablet in a cup, and disperse the capsules to participants. While the scientist notes who received which type of pill, subjects are oblivious.
Here, the researcher remains biased, anticipating that the sleep-aid will work. Thus, during observation, she may note that those administered the drug fell asleep faster, while in reality there is no difference between groups.
However, participant biases are eliminated. Since subjects don't know if they swallowed the sleep-aid, they lack expectations regarding the efficacy of the pill. Consequently, they’ll accurately state how their insomnia was affected.
This method, where only researchers or participants realize who obtained treatment, is termed a single-blind study. However, this procedure can result in one group—here, the scientist—remaining biased.
To circumvent this, double-blind studies are performed, where both participants and the data-collecting researchers are “blind”. Here, the scientist may give the placebo and sleep-aid to a colleague, who re-labels the pills as “Type Y” and “Type Z” before dispersing them.
This coding system eliminates the researcher’s expectations during assessment—she doesn’t know which participants received the medication, and can’t assume who should sleep better. Consequently, she’ll record if someone appears restless.
As before, subjects will also precisely describe their sleep experience. It’s only after data analysis that everyone learns who was administered the sleep-aid or placebo.
Overall, blind procedures help to minimize biases and produce accurate results, which can be used to assess the efficacy of medication and other treatments.
View the full transcript and gain access to JoVE Core videos
Q1: What is experimenter bias and how does it affect research results?
Experimenter bias occurs when a researcher's expectations skew study results. For example, a scientist expecting a sleep-aid to work may note that medicated participants fell asleep faster, even when no actual difference exists. The researcher's anticipation influences how they observe and record data, potentially portraying treatments as more effective than they truly are. Blind procedures help minimize this bias.
Q2: How does a single-blind study control for participant bias?
In a single-blind study, participants remain unaware of whether they received treatment or a placebo, while researchers know group assignments. Since subjects don't know what they received, they lack expectations about efficacy and report their experiences accurately. However, the researcher remains biased during observation and data collection, potentially influencing results through their own expectations.
Q3: What is the placebo effect and why does it matter in research?
The placebo effect occurs when people's expectations or beliefs influence their actual experience. For instance, a participant expecting a pill to improve mood may feel better simply because they took it, not due to any active drug. This expectation-driven response can confound research results, making it difficult to determine whether treatment effects are real or caused by participant expectations alone.
Q4: How does a double-blind study eliminate both researcher and participant bias?
In a double-blind study, neither researchers nor participants know group assignments. A colleague relabels pills as Type Y or Type Z before distribution, preventing the researcher from knowing who received treatment. This coding system eliminates researcher expectations during data collection. Participants also remain blind, preventing placebo effects. Only after analysis does everyone learn actual group assignments.
Q5: Why is blinding important when testing medication effectiveness?
Blinding ensures that observed differences between treatment and control groups reflect actual drug effects rather than bias or expectations. Without blinding, researchers might unconsciously favor treated participants, and participants might experience placebo effects. By keeping both groups blind to assignments, researchers can confidently attribute mood improvements or other outcomes to the medication itself, not to experimenter bias or participant expectations.
Q6: What happens to data collection when researchers know which participants received treatment?
When researchers know treatment assignments, their expectations can bias observations. They may pay more attention to treated participants, interpret ambiguous behaviors favorably for the treatment group, or unconsciously record data differently. This selective attention and interpretation skew results, making treatments appear more effective than they actually are. Blinding the researcher prevents these unconscious influences on data recording.
Q7: How do blind procedures improve the reliability and validity of research findings?
Blind procedures minimize both experimenter and participant biases, producing more accurate results. By preventing researchers from knowing assignments, observations remain objective. By keeping participants unaware, placebo effects are controlled. These protections ensure that measured differences reflect true treatment effects rather than expectations or biases. Consequently, blind procedures strengthen the reliability and validity of conclusions about medication and treatment efficacy.